| abstract |
Heterobicyclic compounds of Formula (I) are provided: (see Formula) or a pharmaceutically acceptable salt, tautomer, or stereoisomer thereof, as defined in the specification, and compositions containing them, and processes for preparing said compounds. Methods for treating disorders or diseases that can be treated by inhibition of PDE10, such as obesity, non-insulin dependent diabetes, schizophrenia, bipolar disorder, obsessive compulsive disorder, Huntington's disease, and the like are also provided herein. |